In GBM, increased CcO activity and increased expression of CcO subunit 4 isoform 1 (COX4-1) have been associated with acquisition of TMZ chemoresistance [12] as well as shorter progression-free and overall survival of patients [23]. The gene discussed is RYR1; the disease is glioblastoma.